A role for T-lymphocytes in human breast cancer and in canine mammary tumors

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Carvalho, Maria Isabel ^a   Pires, Isabel ^a   Prada, Justina ^a   Queiroga, Felisbina L ^b,c,d  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGENICITY; BREAST CANCER; BREAST TUMOR; CANCER GROWTH; CANCER IMMUNOLOGY; CANCER PROGNOSIS; CARCINOGENESIS; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; NONHUMAN; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; REGULATORY T LYMPHOCYTE; REVIEW; SURVIVAL RATE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; DOG; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; TUMOR ASSOCIATED LEUKOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; BREAST NEOPLASMS; DOGS; FEMALE; HUMANS; INFLAMMATION; LYMPHOCYTES, TUMOR-INFILTRATING; MAMMARY NEOPLASMS, ANIMAL; T-LYMPHOCYTES;

EID: 84896852722     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/130894     Document Type: Review

References (100)

1. Prestwich R. J., Errington F., Hatfield P., Merrick A. E., Ilett E. J., Selby P. J., Melcher A. A., The immune system-is it relevant to cancer development, progression and treatment? Clinical Oncology 2008 20 2 101 112 2-s2.0-38849123209 10.1016/j.clon.2007.10.011
2. Medzhitov R., Origin and physiological roles of inflammation. Nature 2008 454 7203 428 435 2-s2.0-47949099098 10.1038/nature07201
3. de Visser K. E., Eichten A., Coussens L. M., Paradoxical roles of the immune system during cancer development. Nature Reviews Cancer 2006 6 1 24 37 2-s2.0-30144443269 10.1038/nrc1782
4. Coussens L. M., Werb Z., Inflammatory cells and cancer: think different! Journal of Experimental Medicine 2001 193 6 F23 F26 2-s2.0-0035911230
5. Vesely M. D., Kershaw M. H., Schreiber R. D., Smyth M. J., Natural innate and adaptive immunity to cancer. Annual Review of Immunology 2011 29 235 271 2-s2.0-79953059789 10.1146/annurev-immunol-031210-101324
6. de Visser K. E., Coussens L. M., The inflammatory tumor microenvironment and its impact on cancer development. Contributions to Microbiology 2006 13 118 137 2-s2.0-33746040164
7. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
8. Ben-Baruch A., Host microenvironment in breast cancer development. Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Research 2003 5 1 31 36 2-s2.0-0038066574 10.1186/bcr554
9. Mihm M. C. Jr., Clemente C. G., Cascinelli N., Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Laboratory Investigation 1996 74 1 43 47 2-s2.0-0030052833
10. Demaria S., Pikarsky E., Karin M., Coussens L. M., Chen Y., El-Omar E. M., Trinchieri G., Dubinett S. M., Mao J. T., Szabo E., Krieg A., Weiner G. J., Fox B. A., Coukos G., Wang E., Abraham R. T., Carbone M., Lotze M. T., Cancer and inflammation: promise for biologic therapy. Journal of Immunotherapy 2010 33 4 335 351 2-s2.0-77954954369 10.1097/CJI.0b013e3181d32e74
11. Sethi G., Shanmugam M. K., Ramachandran L., Kumar A. P., Tergaonkar V., Multifaceted link between cancer and inflammation. Bioscience Reports 2012 32 1 1 15 2-s2.0-84856919722 10.1042/BSR20100136
12. Finn O. J., Molecular origins of cancer: cancer immunology. The New England Journal of Medicine 2008 358 25 2704 2715 2-s2.0-45549092607 10.1056/NEJMra072739
13. Morrison W. B., Inflammation and cancer: a comparative view. Journal of Veterinary Internal Medicine 2012 26 1 18 31 2-s2.0-84855720904 10.1111/j.1939-1676.2011.00836.x
14. Grivennikov S. I., Greten F. R., Karin M., Immunity, inflammation, and cancer. Cell 2010 140 6 883 899 2-s2.0-77950346282 10.1016/j.cell.2010.01.025
15. Aggarwal B. B., Shishodia S., Sandur S. K., Pandey M. K., Sethi G., Inflammation and cancer: how hot is the link? Biochemical Pharmacology 2006 72 11 1605 1621 2-s2.0-33750497844 10.1016/j.bcp.2006.06.029
16. Aggarwal B. B., Gehlot P., Inflammation and cancer: how friendly is the relationship for cancer patients? Current Opinion in Pharmacology 2009 9 4 351 369 2-s2.0-68849108869 10.1016/j.coph.2009.06.020
17. Balkwill F., Mantovani A., Cancer and inflammation: implications for pharmacology and therapeutics. Clinical Pharmacology and Therapeutics 2010 87 4 401 406 2-s2.0-77949872871 10.1038/clpt.2009.312
18. Hagemann T., Lawrence T., McNeish I., Charles K. A., Kulbe H., Thompson R. G., Robinson S. C., Balkwill F. R., 'Re-educating' tumor-associated macrophages by targeting NF- B. Journal of Experimental Medicine 2008 205 6 1261 1268 2-s2.0-45149134605 10.1084/jem.20080108
19. Macchetti A. H., Marana H. R. C., Silva J. S., de Andrade J. M., Ribeiro-Silva A., Bighetti S., Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement. Clinics 2006 61 3 203 208 2-s2.0-33745908848 10.1590/S1807-59322006000300004
20. Curigliano G., Immunity and autoimmunity: revising the concepts of response to breast cancer. Breast 2011 20 supplement 3 S71 S74 2-s2.0-80054875838 10.1016/S0960-9776(11)70298-3
21. Finke J., Ferrone S., Frey A., Mufson A., Ochoa A., Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunology Today 1999 20 4 158 160 2-s2.0-0032947187 10.1016/S0167-5699(98)01435-2
22. Marrogi A. J., Munshi A., Merogi A. J., Ohadike Y., El-Habashi A., Marrogi O. L., Freeman S. M., Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. International Journal of Cancer 1997 74 492 501
23. Sheu B., Kuo W., Chen R., Huang S., Chang K., Chow S., Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. Breast 2008 17 6 604 610 2-s2.0-56649094469 10.1016/j.breast.2008.06.001
24. DeNardo D. G., Coussens L. M., Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Research 2007 9 4, article 212 2-s2.0-40349094954 10.1186/bcr1746
25. Campbell M. J., Scott J., Maecker H. T., Park J. W., Esserman L. J., Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Research and Treatment 2005 91 2 163 171 2-s2.0-18844428908 10.1007/s10549-004-7048-0
26. Goto S., Sato M., Kaneko R., Itoh M., Sato S., Takeuchi S., Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunology Immunotherapy 1999 48 8 435 442 2-s2.0-0032740961 10.1007/s002620050620
27. Gooden M. J. M., de Bock G. H., Leffers N., Daemen T., Nijman H. W., The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. British Journal of Cancer 2011 105 1 93 103 2-s2.0-79959745851 10.1038/bjc.2011.189
28. Mantovani A., Marchesi F., Porta C., Sica A., Allavena P., Inflammation and cancer: breast cancer as a prototype. Breast 2007 16 supplement 2 27 33 2-s2.0-35648933886 10.1016/j.breast.2007.07.013
29. von Boehmer H., Daniel C., Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nature Reviews Drug Discovery 2013 12 51 63
30. Sakaguchi S., Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Regulatory T cells: how do they suppress immune responses? International Immunology 2009 21 10 1105 1111 2-s2.0-70349512606 10.1093/intimm/dxp095
31. Tanchot C., Terme M., Pere H., Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenvironment 2013 6 2 147 157
32. Almand B., Clark J. I., Nikitina E., van Beynen J., English N. R., Knight S. C., Carbone D. P., Gabrilovich D. I., Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. Journal of Immunology 2001 166 1 678 689 2-s2.0-0035164478
33. Ostrand-Rosenberg S., Sinha P., Myeloid-derived suppressor cells: linking inflammation and cancer. Journal of Immunology 2009 182 8 4499 4506 2-s2.0-65249138393 10.4049/jimmunol.0802740
34. Sfanos K. S., Bruno T. C., Maris C. H., Xu L., Thoburn C. J., Demarzo A. M., Meeker A. K., Isaacs W. B., Drake C. G., Phenotypic analysis of prostate-infiltrating lymphocytes reveals T H17 and Treg skewing. Clinical Cancer Research 2008 14 11 3254 3261 2-s2.0-48849103649 10.1158/1078-0432.CCR- 07-5164
35. Martin F., Apetoh L., Ghiringhelli F., Controversies on the role of Th17 in cancer: a TGF-beta-dependent immunosuppressive activity? Trends in Molecular Medicine 2012 18 12 742 749
36. Ye J., Livergood R. S., Peng G., The role and regulation of human Th17 cells in tumor immunity. The American Journal of Pathology 2013 182 10 20
37. Kryczek I., Banerjee M., Cheng P., Vatan L., Szeliga W., Wei S., Huang E., Finlayson E., Simeone D., Welling T. H., Chang A., Coukos G., Liu R., Zou W., Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009 114 6 1141 1149 2-s2.0-69849107597 10.1182/blood-2009-03-208249
38. Novitskiy S. V., Pickup M. W., Gorska A. E., TGF-beta receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discovery 2011 1 430 441
39. Kuroda H., Tamaru J., Sakamoto G., Ohnisi K., Itoyama S., Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Archiv 2005 446 1 10 14 2-s2.0-13144253138 10.1007/s00428-004-1143-9
40. Yakirevich E., Lefel O., Sova Y., Stein A., Cohen O., Izhak O. B., Resnick M. B., Fractalkine expression in human renal inflammation. Journal of Pathology 2002 196 1 85 90 2-s2.0-0036145122 10.1002/path.1010
41. Hadrup S. R., Brændstrup O., Jacobsen G. K., Mortensen S., Pedersen L. Ø., Seremet T., Andersen M. H., Becker J. C., Straten P. T., Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells. International Journal of Cancer 2006 119 4 831 838 2-s2.0-33745883545 10.1002/ijc.21894
42. Piras F., Colombari R., Minerba L., Murtas D., Floris C., Maxia C., Corby A., Perra M. T., Sirigu P., The predictive value of CD8, CD4, CD68 and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer 2005 104 6 1246 1254 2-s2.0-24644488201 10.1002/cncr.21283
43. Taylor R. C., Patel A., Panageas K. S., Busam K. J., Brady M. S., Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. Journal of Clinical Oncology 2007 25 7 869 875 2-s2.0-33947540564 10.1200/JCO.2006.08.9755
44. Pagès F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., Mlecnik B., Kirilovsky A., Nilsson M., Damotte D., Meatchi T., Bruneval P., Cugnenc P., Trajanoski Z., Fridman W., Galon J., Effector memory T cells, early metastasis, and survival in colorectal cancer. The New England Journal of Medicine 2005 353 25 2654 2666 2-s2.0-29144514645 10.1056/NEJMoa051424
45. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pagès C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohoué F., Bruneval P., Cugnenc P., Trajanoski Z., Fridman W., Pagès F., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006 313 5795 1960 1964 2-s2.0-33749319703 10.1126/science.1129139
46. Piersma S. J., Jordanova E. S., van Poelgeest M. I. E., Kwappenberg K. M. C., van Der Hulst J. M., Drijfhout J. W., Melief C. J. M., Kenter G. G., Fleuren G. J., Offringa R., van Der Burg S. H., High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Research 2007 67 1 354 361 2-s2.0-33846444354 10.1158/0008-5472.CAN-06-3388
47. Zhang L., Conejo-Garcia J. R., Katsaros D., Gimotty P. A., Massobrio M., Regnani G., Makrigiannakis A., Gray H., Schlienger K., Liebman M. N., Rubin S. C., Coukos G., Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. The New England Journal of Medicine 2003 348 3 203 213 2-s2.0-0037448353 10.1056/NEJMoa020177
48. Tomšová M., Melichar B., Sedláková I., Šteiner I., Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecologic Oncology 2008 108 2 415 420 2-s2.0-38649133581 10.1016/j.ygyno.2007.10.016
49. Sharma P., Shen Y., Wen S., Yamada S., Jungbluth A. A., Gnjatic S., Bajorin D. F., Reuter V. E., Herr H., Old L. J., Sato E., CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2007 104 10 3967 3972 2-s2.0-34247271873 10.1073/pnas.0611618104
50. Lee H. E., Chae S. W., Lee Y. J., Kim M. A., Lee H. S., Lee B. L., Kim W. H., Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. British Journal of Cancer 2008 99 10 1704 1711 2-s2.0-55949118778 10.1038/sj.bjc.6604738
51. Mohammed Z. M., Going J. J., Edwards J., McMillan D. C., The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer. Cancer Treatment Reviews 2012 38 943 955
52. Aaltomaa S., Lipponen P., Prognostic factors in breast-cancer (review). International Journal of Oncology 1992 1 153 159
53. Carlomagno C., Perrone F., Lauria R., de Laurentiis M., Gallo C., Morabito A., Pettinato G., Panico L., Bellelli T., Apicella A., Petrella G., Bianco A. R., de Placido S., Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. Oncology 1995 52 4 272 277 2-s2.0-0029050638
54. Ménard S., Tomasic G., Casalini P., Balsari A., Pilotti S., Cascinelli N., Salvadori B., Colnaghi M. I., Rilke F., Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clinical Cancer Research 1997 3 5 817 819 2-s2.0-1842338058
55. Marsigliante S., Biscozzo L., Marra A., Nicolardi G., Leo G., Lobreglio G. B., Storelli C., Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens. Cancer Letters 1999 139 1 33 41 2-s2.0-0032902729 10.1016/S0304-3835(98)00379-6
56. Georgiannos S. N., Renaut A., Goode A. W., Sheaff M., The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. Surgery 2003 134 5 827 834 2-s2.0-0348134670 10.1016/S0039-6060(03)00292-7
57. Lee A. H. S., Gillett C. E., Ryder K., Fentiman I. S., Miles D. W., Millis R. R., Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology 2006 48 6 692 701 2-s2.0-33645957984 10.1111/j.1365-2559.2006.02410.x
58. Al Murri A. M., Hilmy M., Bell J., Wilson C., McNicol A.-M., Lannigan A., Doughty J. C., McMillan D. C., The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. British Journal of Cancer 2008 99 7 1013 1019 2-s2.0-53049083445 10.1038/sj.bjc.6604667
59. Calabrò A., Beissbarth T., Kuner R., Stojanov M., Benner A., Asslaber M., Ploner F., Zatloukal K., Samonigg H., Poustka A., Sültmann H., Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Research and Treatment 2009 116 1 69 77 2-s2.0-67649421579 10.1007/s10549-008-0105-3
60. Rakha E. A., Aleskandarany M., El-Sayed M. E., Blamey R. W., Elston C. W., Ellis I. O., Lee A. H. S., The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. European Journal of Cancer 2009 45 10 1780 1787 2-s2.0-66949168510 10.1016/j.ejca.2009. 02.014
61. Rody A., Holtrich U., Pusztai L., Liedtke C., Gaetje R., Ruckhaeberle E., Solbach C., Hanker L., Ahr A., Metzler D., Engels K., Karn T., Kaufmann M., T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Research 2009 11 2, article R15 2-s2.0-67651193848 10.1186/bcr2234
62. Matkowski R., Gisterek I., Halon A., Lacko A., Szewczyk K., Staszek U., Pudelko M., Szynglarewicz B., Szelachowska J., Zolnierek A., Kornafel J., The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Research 2009 29 7 2445 2451 2-s2.0-69249174148
63. Baker K., Lachapelle J., Zlobec I., Bismar T. A., Terracciano L., Foulkes W. D., Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade. Histopathology 2011 58 7 1107 1116 2-s2.0-79959755351 10.1111/j.1365-2559.2011.03846.x
64. Ladoire S., Mignot G., Dabakuyo S., Arnould L., Apetoh L., Rébé C., Coudert B., Martin F., Bizollon M. H., Vanoli A., Coutant C., Fumoleau P., Bonnetain F., Ghiringhelli F., In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. Journal of Pathology 2011 224 3 389 400 2-s2.0-79958189573 10.1002/path.2866
65. Liu F., Lang R., Zhao J., Zhang X., Pringle G. A., Fan Y., Yin D., Gu F., Yao Z., Fu L., CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Research and Treatment 2011 130 2 645 655 2-s2.0-82955181004 10.1007/s10549-011-1646-4
66. Mahmoud S. M. A., Paish E. C., Powe D. G., Macmillan R. D., Grainge M. J., Lee A. H. S., Ellis I. O., Green A. R., Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. Journal of Clinical Oncology 2011 29 15 1949 1955 2-s2.0-79956329617 10.1200/JCO.2010.30.5037
67. West N. R., Milne K., Truong P. T., Macpherson N., Nelson B. H., Watson P. H., Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Research 2011 13 6, article R126 2-s2.0-82955217260 10.1186/bcr3072
68. Ruffell B., Au A., Rugo H. S., Esserman L. J., Hwang E. S., Coussens L. M., Leukocyte composition of human breast cancer. Proceedings of the National Academy of Sciences of the United States of America 2012 109 8 2796 2801 2-s2.0-84857391089 10.1073/pnas.1104303108
69. Lee S., Cho E. Y., Park Y. H., Ahn J. S., Im Y. H., Prognostic impact of FOXP3 expression in triple-negative breast cancer. Acta Oncologica 2013 52 1 73 81
70. Kim S. T., Jeong H., Woo O. H., Seo J. H., Kim A., Lee E. S., Shin S. W., Kim Y. H., Kim J. S., Park K. H., Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. American Journal of Clinical Oncology 2013 36 3 224 231 2-s2.0-84859492161 10.1097/COC.0b013e3182467d90
71. Wang J., Cai D., Ma B., Wu G., Wu J., Skewing the balance of regulatory T-cells and T-helper 17 cells in breast cancer patients. Journal of International Medical Research 2011 39 3 691 701 2-s2.0-80052214987
72. Sorenmo K. U., Rasotto R., Zappulli V., Goldschmidt M. H., Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. Veterinary Pathology 2011 48 1 85 97 2-s2.0-79951878865 10.1177/0300985810389480
73. Queiroga F. L., Raposo T., Carvalho M. I., Prada J., Pires I., Canine mammary tumours as a model to study human breast cancer: most recent findings. In Vivo 2011 25 3 455 465 2-s2.0-79956347959
74. Pérez J., Day M. J., Mozos E., Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth. Veterinary Immunology and Immunopathology 1998 64 2 133 147 2-s2.0-0032496909 10.1016/S0165-2427(98)00131-7
75. Nicholls P. K., Moore P. F., Anderson D. M., Moore R. A., Parry N. R., Gough G. W., Stanley M. A., Regression of canine oral papillomas is associated with infiltration of CDA+ and CD8+ lymphocytes. Virology 2001 283 1 31 39 2-s2.0-0035946296 10.1006/viro.2000.0789
76. Cockerell G. L., Slauson D. O., Patterns of lymphoid infiltrate in the canine cutaneous histiocytoma. Journal of Comparative Pathology 1979 89 2 193 203 2-s2.0-0018380883
77. Grieco V., Rondena M., Romussi S., Stefanello D., Finazzi M., Immunohistochemical characterization of the leucocytic infiltrate associated with canine seminomas. Journal of Comparative Pathology 2004 130 4 278 284 2-s2.0-1842740249 10.1016/j.jcpa.2003.12.001
78. Estrela-Lima A., Araújo M. S. S., Costa-Neto J. M., Teixeira-Carvalho A., Barrouin-Melo S. M., Cardoso S. V., Martins-Filho O. A., Serakides R., Cassali G. D., Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer 2010 10, article 256 2-s2.0-77953005050 10.1186/1471-2407-10-256
79. Kim J.-H., Yu C.-H., Yhee J.-Y., Im K.-S., Sur J.-H., Lymphocyte infiltration, expression of interleukin (IL)-1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours. Journal of Comparative Pathology 2010 142 2-3 177 186 2-s2.0-77649272945 10.1016/j.jcpa.2009.10.023
80. Carvalho M. I., Pires I., Prada J., Queiroga F. L., T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications. In Vivo 2011 25 6 963 969 2-s2.0-80755159156
81. Saeki K., Endo Y., Uchida K., Nishimura R., Sasaki N., Nakagawa T., Significance of tumor-infiltrating immune cells in spontaneous canine mammary gland tumor: 140 cases. Journal of Veterinary Medical Science 2012 74 2 227 230 2-s2.0-84857822520 10.1292/jvms.11-0118
82. Kim J. H., Hur J. H., Lee S. M., Im K. S., Kim N. H., Sur J. H., Correlation of Foxp3 positive regulatory T cells with prognostic factors in canine mammary carcinomas. Veterinary Journal 2012 193 222 227 2-s2.0-82055189893
83. Kim J. H., Chon S. K., Im K. S., Kim N. H., Sur J. H., Correlation of tumor-infiltrating lymphocytes to histopathological features and molecular phenotypes in canine mammary carcinoma: a morphologic and immunohistochemical morphometric study. Canadian Journal of Veterinary Research 2013 77 142 149
84. Knowles G., O'Neil B. W., Campo M. S., Phenotypical characterization of lymphocytes infiltrating regressing papillomas. Journal of Virology 1996 70 12 8451 8458 2-s2.0-0029910846
85. Pires I., Queiroga F. L., Alves A., Silva F., Lopes C., Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression. Anticancer Research 2009 29 7 2713 2717 2-s2.0-69249189530
86. Horiuchi Y., Hanazawa A., Nakajima Y., Nariai Y., Asanuma H., Kuwabara M., Yukawa M., Ito H., T-helper (Th) 1/ Th2 imbalance in the peripheral blood of dogs with malignant tumor. Microbiology and Immunology 2007 51 11 1135 1138 2-s2.0-36349002462
87. Gupta S., Joshi K., Wig J. D., Arora S. K., Intratumoral FOXP3 expression in infiltrating breast carcinoma: its association with clinicopathologic parameters and angiogenesis. Acta Oncologica 2007 46 6 792 797 2-s2.0-34547210257 10.1080/02841860701233443
88. Mougiakakos D., Choudhury A., Lladser A., Kiessling R., Johansson C. C., Regulatory T cells in cancer. Advances in Cancer Research 2010 107 57 117 2-s2.0-77951626075 10.1016/S0065-230X(10)07003-X
89. Biller B. J., Elmslie R. E., Burnett R. C., Avery A. C., Dow S. W., Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Veterinary Immunology and Immunopathology 2007 116 1-2 69 78 2-s2.0-33847152638 10.1016/j.vetimm.2006.12.002
90. Biller B. J., Guth A., Burton J. H., Dow S. W., Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. Journal of Veterinary Internal Medicine 2010 24 5 1118 1123 2-s2.0-77957904791 10.1111/j.1939-1676.2010.0557.x
91. Kim J. H., Chon S. K., Im K. S., Kim N. H., Cho K. W., Sur J. H., Infiltrating Foxp3+ regulatory T cells and histopathological features in canine classical and spermatocytic seminomas. Reproduction in Domestic Animals 2013 48 218 222
92. Kumaraguruparan R., Prathiba D., Nagini S., Of humans and canines: immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours. Research in Veterinary Science 2006 81 2 218 224 2-s2.0-33746916455 10.1016/j.rvsc.2005.08.002
93. Paoloni M. C., Khanna C., Comparative oncology today. Veterinary Clinics of North America 2007 37 6 1023 1032 2-s2.0-35348812507 10.1016/j.cvsm.2007.08. 003
94. Uva P., Aurisicchio L., Watters J., Loboda A., Kulkarni A., Castle J., Palombo F., Viti V., Mesiti G., Zappulli V., Marconato L., Abramo F., Ciliberto G., Lahm A., La Monica N., de Rinaldis E., Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics 2009 10, article 135 2-s2.0-65249091846 10.1186/1471-2164-10-135
95. Lindblad-Toh K., Wade C. M., Mikkelsen T. S., Karlsson E. K., Jaffe D. B., Kamal M., Clamp M., Chang J. L., Kulbokas E. J. III, Zody M. C., Mauceli E., Xie X., Breen M., Wayne R. K., Ostrander E. A., Ponting C. P., Galibert F., Smith D. R., DeJong P. J., Kirkness E., Alvarez P., Biagi T., Brockman W., Butler J., Chin C., Cook A., Cuff J., Daly M. J., DeCaprio D., Gnerre S., Grabherr M., Kellis M., Kleber M., Bardeleben C., Goodstadt L., Heger A., Hitte C., Kim L., Koepfli K., Parker H. G., Pollinger J. P., Searle S. M. J., Sutter N. B., Thomas R., Webber C., Lander E. S., Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005 438 7069 803 819 2-s2.0-28644447707 10.1038/nature04338
96. Joy F., Basak S., Gupta S. K., Das P. J., Ghosh S. K., Ghosh T. C., Compositional correlations in canine genome reflects similarity with human genes. Journal of Biochemistry and Molecular Biology 2006 39 3 240 246 2-s2.0-33744949757
97. Ben-Baruch A., Breast cancer progression: a "Vicious Cycle" of pro-malignancy activities is mediated by inflammatory cells, chemokines and cytokines. Integration/Interaction of Oncologic Growth 2005 Amsterdam, The Netherlands Springer 189 217
98. Balkwill F., Mantovani A., Inflammation and cancer: back to Virchow? The Lancet 2001 357 9255 539 545 2-s2.0-0035901090 10.1016/S0140-6736(00)04046-0
99. Curigliano G., Spitaleri G., Petri E., Rescigno M., de Braud F., Cardillo A., Munzone E., Rocca A., Bonizzi G., Brichard V., Orlando L., Goldhirsch A., Breast cancer vaccines: a clinical reality or fairy tale? Annals of Oncology 2006 17 5 750 762 2-s2.0-33646170120 10.1093/annonc/mdj083
100. Acres B., Limacher J., Bonnefoy J., Discovery and development of therapeutic cancer vaccines. Current Opinion in Drug Discovery and Development 2007 10 2 185 192 2-s2.0-33947322905